세계의 영상 유도 방사선 치료 시장 : 제품별, 시술별, 최종 사용자별 - 기회 분석 및 산업 예측(2024-2033년)

Image-Guided Radiation Therapy Market By Product, By Procedure (IMRT, Stereotactic Therapy, Particle Therapy, Others) By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

US $ 4,425 ￦ 6,152,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,304,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

영상 유도 방사선 치료 시장

영상 유도 방사선 치료 시장은 2023년 19억 달러로 평가되었고, 2024년부터 2033년까지 연평균 5.7% 성장하여 2033년에는 33억 달러에 달할 것으로 예상됩니다.

영상 유도 방사선 치료는 암 치료에 자주 사용되는 영상 처리 과정입니다. 이 치료법에는 MRI, PET, CT 스캔과 같은 여러 영상 기술이 포함되며, 암세포를 죽이기 위해 방사선을 정확하게 표적화하여 암세포를 죽일 수 있습니다. 정확한 타겟팅은 영상 기술로 생성된 고화질 이미지를 통해 이루어집니다. 이러한 접근 방식은 치료의 정확성을 높이고 치료 결과를 개선하며 방사선 관련 합병증을 감소시켜 영상 유도 방사선 치료는 현대 종양학 진료에서 필수적인 치료법으로 자리 잡았습니다.

영상 유도 방사선 치료 시장의 주요 촉진요인은 다양한 암의 유병률 증가와 표적화된 암 치료에 대한 수요 증가입니다. 또한, 치료 중 실시간 영상 진단의 도입은 치료 효과를 높여 영상 유도 방사선 치료 수요를 증가시키고 있습니다. 표면 유도 방사선 치료는 분주 내 운동 모니터링 및 호흡 게이팅과 같은 최첨단 특성으로 인해 최근 여러 종양 시설에서 널리 채택되고 있습니다.

그러나 영상유도방사선치료와 관련된 장비 조달 비용과 높은 환자 치료비용이 시장의 주요 억제요인으로 작용하고 있습니다. 반대로 기술의 발전은 치료의 전망을 다양화하고 치료 과정을 정교하게 만들고 있으며, AI와 ML의 융합은 환자의 바이탈과 요구에 따라 맞춤형 암 치료를 제공할 수 있게 해줍니다. 예를 들어, 교모세포종 환자의 경우, AI 기반 선량 최적화 소프트웨어가 방사선 치료를 조정하는 데 사용되었습니다. 이를 통해 뇌간과 시신경과 같은 뇌의 중요한 부분을 보호하면서 종양을 최대한 억제할 수 있는 최적의 방사선 선량으로 치료할 수 있었습니다.

부문별 리뷰

영상 유도 방사선 치료 시장은 제품, 시술, 최종 사용자, 지역으로 구분됩니다. 제품별로는 4D RT, 리니어릭, MRI 유도 방사선 치료, 포털 이미징, CT 스캔으로 분류됩니다. 시술별로는 IMRT(강도변조방사선치료), 정위치료, 입자선치료, 기타로 분류됩니다. 최종 사용자별로는 병원, 독립 방사선치료센터, 기타로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, LAMEA로 분석됩니다.

주요 조사 결과

제품별로는 리니어릭이 시장을 독점하고 있습니다.

기술별로는 IMRT(강도변조방사선치료) 분야가 시장을 선도하고 있습니다.

지역별로는 북미가 2033년까지 가장 높은 수익을 올릴 것으로 예상됩니다.

이 보고서는 사용자 정의가 가능합니다.

• 고객의 관심사에 따른 기업 프로파일 추가

목차

제1장 서론

제2장 주요 요약

제3장 시장 구도

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter의 Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회

제4장 영상 유도 방사선 치료 시장 : 제품별

• 시장 개요
• 4D RT
• LINAC
• MRI 가이드하 방사선 치료
• 포털 이미징
• CT 스캔

제5장 영상 유도 방사선 치료 시장 : 시술별

• 시장 개요
• IMRT(강도조절 방사선 치료)
• 정위 방사선 치료
• 입자선 치료
• 기타

제6장 영상 유도 방사선 치료 시장 : 최종사용자별

• 시장 개요
• 병원
• 독립 방사선 치료 센터
• 기타

제7장 영상 유도 방사선 치료 시장 : 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국 영상 유도 방사선 치료 시장
  • 캐나다 영상 유도 방사선 치료 시장
  • 멕시코 영상 유도 방사선 치료 시장
• 유럽
  • 주요 시장 동향과 기회
  • 프랑스 영상 유도 방사선 치료 시장
  • 독일 영상 유도 방사선 치료 시장
  • 이탈리아 영상 유도 방사선 치료 시장
  • 스페인 영상 유도 방사선 치료 시장
  • 영국 영상 유도 방사선 치료 시장
  • 기타 유럽 영상 유도 방사선 치료 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 중국 영상 유도 방사선 치료 시장
  • 일본 영상 유도 방사선 치료 시장
  • 인도 영상 유도 방사선 치료 시장
  • 한국 영상 유도 방사선 치료 시장
  • 호주 영상 유도 방사선 치료 시장
  • 기타 아시아태평양 영상 유도 방사선 치료 시장
• 라틴아메리카/중동 및 아프리카
  • 주요 시장 동향과 기회
  • 브라질 영상 유도 방사선 치료 시장
  • 남아프리카공화국 영상 유도 방사선 치료 시장
  • 사우디아라비아 영상 유도 방사선 치료 시장
  • 기타 라틴아메리카/중동 및 아프리카 영상 유도 방사선 치료 시장

제8장 경쟁 구도

• 서론
• 주요 성공 전략
• 주요 10개 기업의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제9장 기업 개요

• Varian Medical Systems, Inc.
• Elekta AB, Accuray Incorporated
• ViewRay, Inc.
• Siemens Healthineers AG
• Hitachi, Ltd
• Brainlab AG
• MEVION MEDICAL SYSTEMS, INC.
• C-Rad AB
• Sumitomo Heavy Industries, Ltd.
• Philips Healthcare

LSH

영문 목차

영문목차

Image-guided Radiation Therapy Market

The image-guided radiation therapy market was valued at $1.9 billion in 2023 and is projected to reach $3.3 billion by 2033, growing at a CAGR of 5.7% from 2024 to 2033.

Image-guided radiation therapy is a frequent imaging process used in the treatment of cancer. The therapy involves several imaging techniques such as MRI, PET, and CT scans, which allow for precise targeting of radiation for killing the cancer cells. The precise targeting is performed using the high-quality images generated by imaging technologies. This approach elevates the accuracy of treatment, improves therapy outcomes, and reduces radiation-related complications, making image-guided radiation therapy a necessary procedure in modern oncology practice.

Increase in prevalence of diverse forms of cancers and rise in demand for targeted cancer treatment are the major drivers of the image-guided radiation therapy market. In addition, the deployment of real-time imaging during ongoing treatment sessions has boosted the efficacy of treatment, thereby boosting the demand for image-guided radiation therapy. Surface-guided radiation therapy has recently witnessed widespread adoption in several oncology facilities due to its cutting-edge attributes such as intra-fraction motion monitoring and respiratory gating.

However, the cost associated with procuring instruments related to image-guided radiation therapy, along with the high costs of treatment for the patients, is a major restraint for the market. On the contrary, enhancements in technology are diversifying the prospects of the therapy and refining the healing process. Assimilation of AI and ML is enabling the delivery of personalized cancer treatment according to the vitals and requirements of the patient. For instance, in the case of a patient suffering from glioblastoma, an AI-based dose optimization software was used to tailor the radiation therapy. This included the delivery of optimal dose of radiation, resulting in maximum tumor control while guarding the pivotal parts of the brain such as brainstem and optic nerves.

Segment Review

The image-guided radiation therapy market is segmented into product, procedure, end user, and region. On the basis of product, the market is divided into 4D RT, LINAC, MRI-guided radiotherapy, portal imaging, and CT scanning. By procedure, it is classified into IMRT (intensity modulation radiation therapy), stereotactic therapy, particle therapy, and others. Depending on end user, it is categorized into hospitals, independent radiotherapy centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the LINAC segment dominates the market.

By procedure, the IMRT (intensity modulation radiation therapy) segment is the leader in the market.

Region wise, North America is projected to be the highest revenue generator by 2033.

Competition Analysis

The major players operating in the global image-guided radiation therapy market include Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, ViewRay, Inc., Siemens Healthineers AG, Hitachi, Ltd, Brainlab AG, MEVION MEDICAL SYSTEMS, INC., C-Rad AB, Sumitomo Heavy Industries, Ltd., and Philips Healthcare. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Additional company profiles with specific to client's interest

Key Market Segments

By Product

• 4D RT
• LINAC
• MRI-guided Radiotherapy
• Portal Imaging
• CT Scanning

By Procedure

• IMRT (intensity modulation radiation therapy)
• Stereotactic Therapy
• Particle Therapy
• Others

By End User

• Hospitals
• Independent Radiotherapy Centers
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players:

• Varian Medical Systems, Inc.
• Elekta AB, Accuray Incorporated
• ViewRay, Inc.
• Siemens Healthineers AG
• Hitachi, Ltd
• Brainlab AG
• MEVION MEDICAL SYSTEMS, INC.
• C-Rad AB
• Sumitomo Heavy Industries, Ltd.
• Philips Healthcare

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.5. Market Dynamics
  • 3.5.1. Drivers
  • 3.5.2. Restraints
  • 3.5.3. Opportunities

CHAPTER 4: IMAGE-GUIDED RADIATION THERAPY MARKET, BY PRODUCT

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Product
• 4.2. 4D RT
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. LINAC
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country
• 4.4. MRI-guided Radiotherapy
  • 4.4.1. Key Market Trends, Growth Factors and Opportunities
  • 4.4.2. Market Size and Forecast, By Region
  • 4.4.3. Market Share Analysis, By Country
• 4.5. Portal Imaging
  • 4.5.1. Key Market Trends, Growth Factors and Opportunities
  • 4.5.2. Market Size and Forecast, By Region
  • 4.5.3. Market Share Analysis, By Country
• 4.6. CT Scanning
  • 4.6.1. Key Market Trends, Growth Factors and Opportunities
  • 4.6.2. Market Size and Forecast, By Region
  • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: IMAGE-GUIDED RADIATION THERAPY MARKET, BY PROCEDURE

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By Procedure
• 5.2. IMRT (intensity Modulation Radiation Therapy)
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Stereotactic Therapy
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country
• 5.4. Particle Therapy
  • 5.4.1. Key Market Trends, Growth Factors and Opportunities
  • 5.4.2. Market Size and Forecast, By Region
  • 5.4.3. Market Share Analysis, By Country
• 5.5. Others
  • 5.5.1. Key Market Trends, Growth Factors and Opportunities
  • 5.5.2. Market Size and Forecast, By Region
  • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: IMAGE-GUIDED RADIATION THERAPY MARKET, BY END USER

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By End User
• 6.2. Hospitals
  • 6.2.1. Key Market Trends, Growth Factors and Opportunities
  • 6.2.2. Market Size and Forecast, By Region
  • 6.2.3. Market Share Analysis, By Country
• 6.3. Independent Radiotherapy Centers
  • 6.3.1. Key Market Trends, Growth Factors and Opportunities
  • 6.3.2. Market Size and Forecast, By Region
  • 6.3.3. Market Share Analysis, By Country
• 6.4. Others
  • 6.4.1. Key Market Trends, Growth Factors and Opportunities
  • 6.4.2. Market Size and Forecast, By Region
  • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: IMAGE-GUIDED RADIATION THERAPY MARKET, BY REGION

• 7.1. Market Overview
  • 7.1.1 Market Size and Forecast, By Region
• 7.2. North America
  • 7.2.1. Key Market Trends and Opportunities
  • 7.2.2. Market Size and Forecast, By Product
  • 7.2.3. Market Size and Forecast, By Procedure
  • 7.2.4. Market Size and Forecast, By End User
  • 7.2.5. Market Size and Forecast, By Country
  • 7.2.6. U.S. Image-Guided Radiation Therapy Market
    • 7.2.6.1. Market Size and Forecast, By Product
    • 7.2.6.2. Market Size and Forecast, By Procedure
    • 7.2.6.3. Market Size and Forecast, By End User
  • 7.2.7. Canada Image-Guided Radiation Therapy Market
    • 7.2.7.1. Market Size and Forecast, By Product
    • 7.2.7.2. Market Size and Forecast, By Procedure
    • 7.2.7.3. Market Size and Forecast, By End User
  • 7.2.8. Mexico Image-Guided Radiation Therapy Market
    • 7.2.8.1. Market Size and Forecast, By Product
    • 7.2.8.2. Market Size and Forecast, By Procedure
    • 7.2.8.3. Market Size and Forecast, By End User
• 7.3. Europe
  • 7.3.1. Key Market Trends and Opportunities
  • 7.3.2. Market Size and Forecast, By Product
  • 7.3.3. Market Size and Forecast, By Procedure
  • 7.3.4. Market Size and Forecast, By End User
  • 7.3.5. Market Size and Forecast, By Country
  • 7.3.6. France Image-Guided Radiation Therapy Market
    • 7.3.6.1. Market Size and Forecast, By Product
    • 7.3.6.2. Market Size and Forecast, By Procedure
    • 7.3.6.3. Market Size and Forecast, By End User
  • 7.3.7. Germany Image-Guided Radiation Therapy Market
    • 7.3.7.1. Market Size and Forecast, By Product
    • 7.3.7.2. Market Size and Forecast, By Procedure
    • 7.3.7.3. Market Size and Forecast, By End User
  • 7.3.8. Italy Image-Guided Radiation Therapy Market
    • 7.3.8.1. Market Size and Forecast, By Product
    • 7.3.8.2. Market Size and Forecast, By Procedure
    • 7.3.8.3. Market Size and Forecast, By End User
  • 7.3.9. Spain Image-Guided Radiation Therapy Market
    • 7.3.9.1. Market Size and Forecast, By Product
    • 7.3.9.2. Market Size and Forecast, By Procedure
    • 7.3.9.3. Market Size and Forecast, By End User
  • 7.3.10. UK Image-Guided Radiation Therapy Market
    • 7.3.10.1. Market Size and Forecast, By Product
    • 7.3.10.2. Market Size and Forecast, By Procedure
    • 7.3.10.3. Market Size and Forecast, By End User
  • 7.3.11. Rest of Europe Image-Guided Radiation Therapy Market
    • 7.3.11.1. Market Size and Forecast, By Product
    • 7.3.11.2. Market Size and Forecast, By Procedure
    • 7.3.11.3. Market Size and Forecast, By End User
• 7.4. Asia-Pacific
  • 7.4.1. Key Market Trends and Opportunities
  • 7.4.2. Market Size and Forecast, By Product
  • 7.4.3. Market Size and Forecast, By Procedure
  • 7.4.4. Market Size and Forecast, By End User
  • 7.4.5. Market Size and Forecast, By Country
  • 7.4.6. China Image-Guided Radiation Therapy Market
    • 7.4.6.1. Market Size and Forecast, By Product
    • 7.4.6.2. Market Size and Forecast, By Procedure
    • 7.4.6.3. Market Size and Forecast, By End User
  • 7.4.7. Japan Image-Guided Radiation Therapy Market
    • 7.4.7.1. Market Size and Forecast, By Product
    • 7.4.7.2. Market Size and Forecast, By Procedure
    • 7.4.7.3. Market Size and Forecast, By End User
  • 7.4.8. India Image-Guided Radiation Therapy Market
    • 7.4.8.1. Market Size and Forecast, By Product
    • 7.4.8.2. Market Size and Forecast, By Procedure
    • 7.4.8.3. Market Size and Forecast, By End User
  • 7.4.9. South Korea Image-Guided Radiation Therapy Market
    • 7.4.9.1. Market Size and Forecast, By Product
    • 7.4.9.2. Market Size and Forecast, By Procedure
    • 7.4.9.3. Market Size and Forecast, By End User
  • 7.4.10. Australia Image-Guided Radiation Therapy Market
    • 7.4.10.1. Market Size and Forecast, By Product
    • 7.4.10.2. Market Size and Forecast, By Procedure
    • 7.4.10.3. Market Size and Forecast, By End User
  • 7.4.11. Rest of Asia-Pacific Image-Guided Radiation Therapy Market
    • 7.4.11.1. Market Size and Forecast, By Product
    • 7.4.11.2. Market Size and Forecast, By Procedure
    • 7.4.11.3. Market Size and Forecast, By End User
• 7.5. LAMEA
  • 7.5.1. Key Market Trends and Opportunities
  • 7.5.2. Market Size and Forecast, By Product
  • 7.5.3. Market Size and Forecast, By Procedure
  • 7.5.4. Market Size and Forecast, By End User
  • 7.5.5. Market Size and Forecast, By Country
  • 7.5.6. Brazil Image-Guided Radiation Therapy Market
    • 7.5.6.1. Market Size and Forecast, By Product
    • 7.5.6.2. Market Size and Forecast, By Procedure
    • 7.5.6.3. Market Size and Forecast, By End User
  • 7.5.7. South Africa Image-Guided Radiation Therapy Market
    • 7.5.7.1. Market Size and Forecast, By Product
    • 7.5.7.2. Market Size and Forecast, By Procedure
    • 7.5.7.3. Market Size and Forecast, By End User
  • 7.5.8. Saudi Arabia Image-Guided Radiation Therapy Market
    • 7.5.8.1. Market Size and Forecast, By Product
    • 7.5.8.2. Market Size and Forecast, By Procedure
    • 7.5.8.3. Market Size and Forecast, By End User
  • 7.5.9. Rest of LAMEA Image-Guided Radiation Therapy Market
    • 7.5.9.1. Market Size and Forecast, By Product
    • 7.5.9.2. Market Size and Forecast, By Procedure
    • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top Winning Strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

• 9.1. Varian Medical Systems, Inc.
  • 9.1.1. Company Overview
  • 9.1.2. Key Executives
  • 9.1.3. Company Snapshot
  • 9.1.4. Operating Business Segments
  • 9.1.5. Product Portfolio
  • 9.1.6. Business Performance
  • 9.1.7. Key Strategic Moves and Developments
• 9.2. Elekta AB, Accuray Incorporated
  • 9.2.1. Company Overview
  • 9.2.2. Key Executives
  • 9.2.3. Company Snapshot
  • 9.2.4. Operating Business Segments
  • 9.2.5. Product Portfolio
  • 9.2.6. Business Performance
  • 9.2.7. Key Strategic Moves and Developments
• 9.3. ViewRay, Inc.
  • 9.3.1. Company Overview
  • 9.3.2. Key Executives
  • 9.3.3. Company Snapshot
  • 9.3.4. Operating Business Segments
  • 9.3.5. Product Portfolio
  • 9.3.6. Business Performance
  • 9.3.7. Key Strategic Moves and Developments
• 9.4. Siemens Healthineers AG
  • 9.4.1. Company Overview
  • 9.4.2. Key Executives
  • 9.4.3. Company Snapshot
  • 9.4.4. Operating Business Segments
  • 9.4.5. Product Portfolio
  • 9.4.6. Business Performance
  • 9.4.7. Key Strategic Moves and Developments
• 9.5. Hitachi, Ltd
  • 9.5.1. Company Overview
  • 9.5.2. Key Executives
  • 9.5.3. Company Snapshot
  • 9.5.4. Operating Business Segments
  • 9.5.5. Product Portfolio
  • 9.5.6. Business Performance
  • 9.5.7. Key Strategic Moves and Developments
• 9.6. Brainlab AG
  • 9.6.1. Company Overview
  • 9.6.2. Key Executives
  • 9.6.3. Company Snapshot
  • 9.6.4. Operating Business Segments
  • 9.6.5. Product Portfolio
  • 9.6.6. Business Performance
  • 9.6.7. Key Strategic Moves and Developments
• 9.7. MEVION MEDICAL SYSTEMS, INC.
  • 9.7.1. Company Overview
  • 9.7.2. Key Executives
  • 9.7.3. Company Snapshot
  • 9.7.4. Operating Business Segments
  • 9.7.5. Product Portfolio
  • 9.7.6. Business Performance
  • 9.7.7. Key Strategic Moves and Developments
• 9.8. C-Rad AB
  • 9.8.1. Company Overview
  • 9.8.2. Key Executives
  • 9.8.3. Company Snapshot
  • 9.8.4. Operating Business Segments
  • 9.8.5. Product Portfolio
  • 9.8.6. Business Performance
  • 9.8.7. Key Strategic Moves and Developments
• 9.9. Sumitomo Heavy Industries, Ltd.
  • 9.9.1. Company Overview
  • 9.9.2. Key Executives
  • 9.9.3. Company Snapshot
  • 9.9.4. Operating Business Segments
  • 9.9.5. Product Portfolio
  • 9.9.6. Business Performance
  • 9.9.7. Key Strategic Moves and Developments
• 9.10. Philips Healthcare
  • 9.10.1. Company Overview
  • 9.10.2. Key Executives
  • 9.10.3. Company Snapshot
  • 9.10.4. Operating Business Segments
  • 9.10.5. Product Portfolio
  • 9.10.6. Business Performance
  • 9.10.7. Key Strategic Moves and Developments

관련자료